Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
+9.88%
-7.54%
+0.97%
+5.81%
+26.52%
GMRE
Global Medical REIT
$31.29
Login to see Global Medical REIT (GMRE) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid Strengths
Earnings are forecast to grow
Risk Analysis
High risk of cutting its dividend
Chart
$7.63 (+310.09%)
$7.15 (+337.62%)
$6.26 (+399.84%)
$9.19 (+240.48%)
GMRE has Medium Risk Level based on volatility, sector strength, volume, investor confidence, and outlook. Click here to check what is your level of risk
Risks Indicators
Beta greater than 1.0
Low volume
GMRE overall standing based on key factors, offering insights into analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings
Reported a strong earnings
Above analyst estimates
Rating
Rating
Momentum
Momentum
Activity
Activity
High risk of cutting its dividend
Future
Future
Earnings are forecast to grow
GMRE Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
GMRE Street view is extremely bullish and have negative views on the near-term outlook
Average key support and resistance price levels.
Login to displayGMRE Earnings
The TTM reflects 12-month period, providing review of GMRE financial performance.
The company financial health has shown minor improvement, but significant issues remain
Financial Score
What is GMRE current stock price?
What are GMRE stock strengths?
What risks are associated with GMRE stock?
When is GMRE next earnings report?
What is GMRE market cap and volume?
What is GMRE's current Stock IQ?
Should I buy GMRE stock right now?
Is GMRE a Strong Buy right now?
What does a 'Strong Buy' rating mean for GMRE?
What does a 'Strong Sell' rating mean for GMRE?
What factors influence GMRE's Stock IQ?
FIND US ON
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
+9.88%
-7.54%
+0.97%
+5.81%
+26.52%
GMRE
Global Medical REIT
Current Price
$31.29
Stock Insights
Strengths
Earnings are forecast to grow
Risk Analysis
High risk of cutting its dividend
Login to unlock Global Medical REIT (GMRE) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid
Chart
$7.63 (+310.09%)
$7.15 (+337.62%)
$6.26 (+399.84%)
$9.19 (+240.48%)
GMRE Analysts Opinion
GMRE Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings
Reported a strong earnings
Above analyst estimates
Rating
Rating
Momentum
Momentum
Activity
Activity
High risk of cutting its dividend
Future
Future
Earnings are forecast to grow
GMRE Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
GMRE Street view is extremely bullish and have negative views on the near-term outlook
GMRE has Medium Risk Level based on volatility, sector strength, volume, investor confidence, and outlook. Click here to check what is your level of risk
Risks Indicators
Beta greater than 1.0
Low volume
Average key support and resistance price levels.
Login to displayGMRE Earnings
The TTM data reflects the most recent 12-month period, providing overview of GMRE financial performance.
GMRE Financial Health
The company financial health has shown minor improvement, but significant issues remain
Financial Score
GMRE Latest Analysis
Global Medical REIT raised to Buy-equivalent at Citizens.
Today
BD and Opentrons Collaborate to Accelerate Single-Cell Multiomics Discoveries with Robotic Automation. ) a leading global medical technology company and Opentrons Labworks Inc. recognized worldwide for accessible lab automation with more than 10000 robotic systems deployed today announced a multi-year collaboration. Together BD and Opentrons will integrate robotic liquid-handling capabilities into BD single-cell multiomics instruments automating critical experimental steps to accelerate and scal
Wed Oct 8, 2025
Zimmer Biomet Launches Two New Foot and Ankle Solutions for Complex Trauma Cases. Gorilla® Pilon Fusion Plating System Introduced for Complex Ankle Fusions Phantom® TTC Trauma Nail Enhances Treatment Options for Complex Hindfoot Injuries WARSAW Ind. Oct. 8 2025 /PRNewswire/ -- Zimmer Biomet Holdings Inc. (NYSE and SIX: ZBH) a global medical technology leader and...
Wed Oct 8, 2025
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
GMRE Stock trends
GMRE Stock performance
GMRE Stock analysis
GMRE investment strategies
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.
Latest Updates
Overview
Trending
Screener
Insights
Top Rated
Momentum
Earnings
Leaders